Login / Signup

Multi-center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity.

Ashley CrouchTsz Hin NgDenise KelleyTamara KnightStephanie Edwinnull nullChristopher Giuliano
Published in: Pharmacotherapy (2021)
or weight ≥120 kg, apixaban appears to be effective and safe for the treatment of VTE.
Keyphrases
  • venous thromboembolism
  • direct oral anticoagulants
  • atrial fibrillation
  • weight loss
  • metabolic syndrome
  • type diabetes
  • weight gain
  • insulin resistance
  • adipose tissue
  • body weight